Cutter Capital Management »

Arcus Biosciences Incorporated shares owned by Cutter Capital Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Cutter Capital Management from 13F filings

Historical chart of Cutter Capital Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Cutter Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Cutter Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7M 193k 19.10

More positions owned by Cutter Capital Management

Amgen (AMGN)
Merck & Co (MRK)
Amicus Therapeutics (FOLD)
Insmed Com Par $.01 (INSM)
BioMarin Pharmaceutical (BMRN)
Roivant Sciences SHS (ROIV)
Exelixis (EXEL)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Royalty Pharma Shs Class A (RPRX)
ACADIA Pharmaceuticals (ACAD)
BioCryst Pharmaceuticals (BCRX)
Halozyme Therapeutics (HALO)
Perrigo SHS (PRGO)
Pfizer (PFE)
Bristol Myers Squibb (BMY)

View all positions for Cutter Capital Management

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Decheng Capital
Point72 Asset Management
Goldman Sachs Group
Bnp Paribas Investment Partners
Balyasny Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital
Ubs Global Asset Management Americas

View all funds holding Arcus Biosciences Incorporated